Compare
Pennant Group, Inc. vs InnovAge Holding Corp. vs LifeStance Health Group, Inc. vs P3 Health Partners Inc.
| Latest fiscal year | Pennant Group, Inc. PNTG | InnovAge Holding Corp. INNV | LifeStance Health Group, Inc. LFST | P3 Health Partners Inc. PIII |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2026-06-30 | 2025-12-31 | 2025-12-31 |
| Revenue | $947.71M | $989.71M | $1.42B | $1.46B |
| Revenue growth (YoY) | +36.3% | +15.9% | +13.9% | -2.8% |
| Gross margin | n/a | 23.0% | n/a | n/a |
| Operating margin | 5.5% | 0.3% | 1.7% | -18.5% |
| Net margin | 3.1% | -0.3% | 0.7% | -10.1% |
| Net income | $29.58M | -$2.54M | $9.66M | -$147.95M |
| EPS (Diluted) | $0.84 | -$0.02 | n/a | -$45.26 |
| Operating cash flow | $48.29M | $64.71M | $146.15M | -$91.24M |
| Free cash flow | $36.26M | $50.41M | $110.03M | n/a |
| Cash & equivalents | n/a | $97.89M | $248.64M | $25.01M |
| Total assets | $968.18M | $557.39M | $2.20B | $656.64M |
| Total liabilities | $593.93M | $288.62M | $682.92M | $796.88M |
| Shareholders' equity | $374.25M | $235.60M | $1.52B | -$155.23M |
| Return on year-end equity | 7.9% | -1.1% | 0.6% | n/a |
| Shares outstanding | 34.63M | 136.02M | 388.32M | n/a |
Revenue, most recent five fiscal years
| Fiscal year | Pennant Group, Inc. | InnovAge Holding Corp. | LifeStance Health Group, Inc. | P3 Health Partners Inc. |
|---|---|---|---|---|
| Latest | $947.71M Ended 2025-12-31 | $989.71M Ended 2026-06-30 | $1.42B Ended 2025-12-31 | $1.46B Ended 2025-12-31 |
| 1 year earlier | $695.24M Ended 2024-12-31 | $853.70M Ended 2025-06-30 | $1.25B Ended 2024-12-31 | $1.50B Ended 2024-12-31 |
| 2 years earlier | $544.89M Ended 2023-12-31 | $763.86M Ended 2024-06-30 | $1.06B Ended 2023-12-31 | $1.27B Ended 2023-12-31 |
| 3 years earlier | $473.24M Ended 2022-12-31 | $688.09M Ended 2023-06-30 | $859.54M Ended 2022-12-31 | $1.05B Ended 2022-12-31 |
| 4 years earlier | $439.69M Ended 2021-12-31 | $698.64M Ended 2022-06-30 | $667.51M Ended 2021-12-31 | n/a |